Chemoinformaics analysis of 1-FORMYLPIPERAZINE
| Molecular Weight | 114.148 | nRot | 1 |
| Heavy Atom Molecular Weight | 104.068 | nRig | 7 |
| Exact Molecular Weight | 114.079 | nRing | 1 |
| Solubility: LogS | 0.822 | nHRing | 1 |
| Solubility: LogP | -1.538 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 18.0199 |
| nHD | 1 | BPOL | 13.1801 |
| QED | 0.446 |
| Synth | 2.931 |
| Natural Product Likeliness | -0.237 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.919 |
| HIA | 0.033 |
| CACO-2 | -4.934 |
| MDCK | 0.00000334 |
| BBB | 0.44 |
| PPB | 0.216806 |
| VDSS | 1.874 |
| FU | 0.846374 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.103 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.497 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.522 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.675 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.147 |
| CL | 4.686 |
| T12 | 0.751 |
| hERG | 0.015 |
| Ames | 0.032 |
| ROA | 0.037 |
| SkinSen | 0.698 |
| Carcinogencity | 0.054 |
| EI | 0.941 |
| Respiratory | 0.291 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.967242 |